IRIS
PASSALACQUA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 60.257
AS - Asia 5.274
NA - Nord America 2.416
SA - Sud America 421
AF - Africa 83
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 68.463
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 59.235
SG - Singapore 2.407
US - Stati Uniti d'America 2.249
CN - Cina 1.349
VN - Vietnam 790
FR - Francia 495
BR - Brasile 264
FI - Finlandia 197
HK - Hong Kong 184
BD - Bangladesh 178
DE - Germania 101
MX - Messico 71
AR - Argentina 70
JP - Giappone 66
CA - Canada 50
IQ - Iraq 48
GB - Regno Unito 47
IN - India 37
CH - Svizzera 33
NL - Olanda 30
ID - Indonesia 25
PH - Filippine 22
TH - Thailandia 21
EC - Ecuador 19
JO - Giordania 17
RU - Federazione Russa 17
TR - Turchia 17
VE - Venezuela 17
ZA - Sudafrica 17
EG - Egitto 16
ES - Italia 16
KR - Corea 15
PK - Pakistan 15
CO - Colombia 14
IE - Irlanda 14
MA - Marocco 12
UA - Ucraina 11
CL - Cile 10
PE - Perù 10
SA - Arabia Saudita 10
JM - Giamaica 9
TW - Taiwan 9
AT - Austria 8
AZ - Azerbaigian 8
DZ - Algeria 8
UY - Uruguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
HN - Honduras 7
LT - Lituania 7
NP - Nepal 7
PT - Portogallo 7
KZ - Kazakistan 6
MY - Malesia 6
NI - Nicaragua 6
BO - Bolivia 5
CR - Costa Rica 5
KE - Kenya 5
RO - Romania 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
PL - Polonia 4
PY - Paraguay 4
BE - Belgio 3
BG - Bulgaria 3
CY - Cipro 3
KG - Kirghizistan 3
MD - Moldavia 3
NE - Niger 3
OM - Oman 3
PA - Panama 3
SE - Svezia 3
SI - Slovenia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BF - Burkina Faso 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
MM - Myanmar 2
NA - Namibia 2
NG - Nigeria 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 68.448
Salva come PNG Salva come JPEG
Città #
Genova 41.035
Genoa 10.367
Rapallo 4.496
Vado Ligure 2.986
Singapore 1.129
San Jose 866
Lauterbourg 481
Ashburn 216
Ho Chi Minh City 212
Helsinki 191
Hanoi 185
New York 184
Hong Kong 175
Beijing 121
Santa Clara 91
Council Bluffs 85
Frankfurt am Main 81
Bordighera 71
Tokyo 60
Mexico City 46
Los Angeles 42
Da Nang 36
Haiphong 36
Tianjin 35
Zurich 29
Rome 27
Milan 22
São Paulo 22
Dallas 21
Baghdad 19
Naples 18
Buffalo 17
City of London 16
Turin 16
Amsterdam 15
Dublin 15
Amman 14
Biên Hòa 14
Chicago 14
Nuremberg 14
Orem 14
Bangkok 13
Des Moines 13
Shanghai 13
Can Tho 12
Cardiff 11
Guangzhou 11
Belo Horizonte 10
Bologna 10
Jakarta 10
Hải Dương 8
Montevideo 8
Nha Trang 8
Quito 8
Rio de Janeiro 8
San Francisco 8
Seattle 8
Toronto 8
Atlanta 7
Baku 7
Dhaka 7
Lima 7
Shenzhen 7
Tashkent 7
Agawam 6
Brooklyn 6
Kingston 6
Phoenix 6
Porto Alegre 6
Quận Ba 6
Thái Bình 6
Buenos Aires 5
Cairo 5
Cape Town 5
Denver 5
East Gwillimbury 5
Guayaquil 5
Houston 5
Hưng Yên 5
Kuala Lumpur 5
London 5
Long Xuyen 5
Madrid 5
Managua 5
Manchester 5
Montreal 5
Quảng Ngãi 5
San Juan 5
Santiago 5
Tân Tiến 5
Vienna 5
Vĩnh Long 5
Ân Thi 5
Bari 4
Bergamo 4
Birmingham 4
Boardman 4
Bắc Ninh 4
Bến Tre 4
Calgary 4
Totale 63.923
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 330
Immunoterapia specifica: una possibilità di gestione del rischio professionale da allergia al veleno di imenotteri 244
A Review of the Evidence from Comparative Studies of Levocetirizine and Desloratadine for the Symptoms of Allergic Rhinitis 211
Adhesion molecules in allergy. 207
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. 207
A critical evaluation of Anti-IL-13 and Anti-IL-4 strategies in severe asthma 204
A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. 203
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early and late phase reactions after allergen-specific challenge. 201
Molecular phenotyping and biomarker development: Are we on our way towards targeted therapy for severe asthma? 197
Personalized medicine in allergy 197
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision 197
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma 194
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects. 192
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 192
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 189
Mepolizumab in the management of severe eosinophilic asthma in adults: Current evidence and practical experience 188
Anti-IL-5 and IL-5Ra: Efficacy and safety of new therapeutic strategies in severe uncontrolled asthma 187
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 187
Local Side Effects of Sublingual and Oral Immunotherapy 184
A survey of clinical features of allergic rhinitis in adults. 183
Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. 182
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life 182
A new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy. 179
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. 177
Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial. 174
A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020 174
A WAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnostics 171
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 170
Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. 170
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. 170
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations. 170
Fibrous invasive (Riedel's) thyroiditis with critical response to steroid treatment. 169
Catching allergy by a simple questionnaire 169
A critical appraisal on AIT in childhood asthma 169
Efficacy of Buffered Hypertonic Saline Nasal Irrigation for Nasal Symptoms in Children with Seasonal Allergic Rhinitis: A Randomized Controlled Trial 169
Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma 168
Nasal cytology: Methodology with application to clinical practice and research 168
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments 168
Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. 167
Current insights in allergen immunotherapy 167
30 Years Of Sublingual Immunotherapy 167
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 167
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations 166
When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation 164
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. 163
Aerobiologic diagnosis of brassicaceae-induced asthma. 162
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. 162
CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children. 161
Allergy and the bone: unexpected relationships. 160
Umeclidinium for the treatment of uncontrolled asthma 160
A prospective italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. 160
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 159
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 159
Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallenge. 158
The safety of monoclonal antibodies in asthma 158
Allergenius, an expert system for the interpretation of allergen microarray results 158
Focus on cat allergen (Fel d 1): immunological and aerodynamic characteristics, modality of airway sensitization and avoidance strategies. 158
Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. 157
MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis 156
Continuous versus on demand treatment with cetirizine for allergic rhinitis. 155
Appropriateness in allergic respiratory diseases health care in Italy: Definitions and organizational aspects 155
Latex-jujube cross-reactivity: case report and immunological study. 154
The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting. 154
Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study 154
[Anti-leukotriene agents: rationale for and prospects of use]. 154
2019 ARIA Care pathways for allergen immunotherapy 154
Molecular diagnosis and precision medicine in allergy management 153
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. 152
The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years 151
Antihistamines in atopic dermatitis. 151
Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma 151
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. 151
When allergic rhinitis is not only allergic. 151
How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. 150
The path to personalized medicine in asthma 150
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation 150
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. 150
Sublingual immunotherapy. 149
The classification of allergic rhinitis and its cytological correlate. 149
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 149
Antihistamines in the treatment of bronchial asthma. Present knowledge and future perspectives 148
Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. 148
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. 148
Hymenoptera venom allergy in outdoor workers: Occupational exposure, clinical features and effects of allergen immunotherapy 148
Effect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period 148
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 148
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 148
Sublingual immunotherapy: World Allergy Organization position paper 2013 update 148
Sublingual and oral immunotherapy. 147
The functional connection between oral allergy syndrome and united airways disease assessed by oral challenge. 147
[Immunotherapy in Latin America. From the past to the future]. 147
Allergen biodistribution in humans 147
Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects. 146
An update on the asthma-rhinitis link. 146
Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis. 146
Is alternative medicine acceptable in allergology? 146
Executive summary of European Task Force document on diagnostic tools in rhinology. 146
Sublingual immunotherapy: other indications. 146
Will sublingual immunotherapy offer benefit for asthma? 146
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 146
Totale 16.709
Salva come PNG Salva come JPEG
Categoria #
all - tutte 216.487
article - articoli 215.323
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.164
Totale 432.974
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 0 0 0 0 0 0 456
2021/20226.596 152 387 560 940 117 560 551 1.378 276 571 310 794
2022/20235.473 598 221 30 477 836 1.112 52 508 1.078 96 388 77
2023/20242.361 177 419 52 195 233 362 122 106 129 47 162 357
2024/20256.939 101 700 275 440 1.060 682 659 861 267 382 575 937
2025/202612.734 1.237 385 854 945 1.457 1.761 2.435 594 954 1.197 703 212
Totale 69.211